News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,007 Results
Type
Article (6849)
Company Profile (110)
Press Release (163048)
Multimedia
Podcasts (46)
Webinars (7)
Section
Business (53854)
Career Advice (356)
Deals (9765)
Drug Delivery (30)
Drug Development (31986)
Employer Resources (69)
FDA (2736)
Job Trends (4148)
News (96565)
Policy (6765)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (259)
Accelerated approval (1)
Adcomms (2)
Allergies (28)
Alliances (12287)
ALS (33)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (56)
Approvals (2760)
Artificial intelligence (71)
Autoimmune disease (8)
Automation (1)
Bankruptcy (64)
Best Places to Work (3219)
BIOSECURE Act (14)
Biosimilars (41)
Biotechnology (72)
Bladder cancer (18)
Brain cancer (13)
Breast cancer (58)
Cancer (639)
Cardiovascular disease (41)
Career advice (308)
Career pathing (21)
CAR-T (55)
Cell therapy (134)
Cervical cancer (4)
Clinical research (27098)
Collaboration (267)
Compensation (268)
Complete response letters (8)
COVID-19 (659)
CRISPR (8)
C-suite (102)
Cystic fibrosis (25)
Data (742)
Decentralized trials (1)
Denatured (12)
Depression (15)
Diabetes (61)
Diagnostics (603)
Digital health (2)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (30)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (21)
Earnings (23095)
Editorial (26)
Employer branding (10)
Employer resources (60)
Events (33915)
Executive appointments (297)
FDA (3078)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (202)
Gene editing (19)
Generative AI (9)
Gene therapy (68)
GLP-1 (247)
Government (736)
Grass and pollen (1)
Guidances (15)
Healthcare (2314)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (32)
Indications (12)
Infectious disease (690)
Inflammatory bowel disease (46)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (36)
Interviews (58)
IPO (5767)
IRA (14)
Job creations (1025)
Job search strategy (261)
Kidney cancer (5)
Labor market (26)
Layoffs (133)
Leadership (13)
Legal (911)
Liver cancer (23)
Lung cancer (103)
Lymphoma (45)
Machine learning (2)
Management (23)
Manufacturing (111)
MASH (40)
Medical device (445)
Medtech (446)
Mergers & acquisitions (4235)
Metabolic disorders (224)
Multiple sclerosis (29)
NASH (8)
Neurodegenerative disease (27)
Neuropsychiatric disorders (7)
Neuroscience (564)
NextGen: Class of 2025 (980)
Non-profit (239)
Northern California (1053)
Now hiring (28)
Obesity (119)
Opinion (77)
Ovarian cancer (30)
Pain (25)
Pancreatic cancer (20)
Parkinson's disease (40)
Partnered (3)
Patents (69)
Patient recruitment (43)
Peanut (15)
People (17263)
Pharmaceutical (38)
Pharmacy benefit managers (1)
Phase I (8196)
Phase II (12490)
Phase III (9106)
Pipeline (457)
Policy (65)
Postmarket research (510)
Preclinical (3058)
Press Release (19)
Prostate cancer (22)
Psychedelics (12)
Radiopharmaceuticals (111)
Rare diseases (101)
Real estate (1203)
Recruiting (29)
Regulatory (5721)
Reports (22)
Research institute (282)
Resumes & cover letters (40)
RNA editing (1)
RSV (11)
Schizophrenia (39)
Series A (35)
Series B (23)
Service/supplier (4)
Sickle cell disease (8)
Southern California (836)
Special edition (16)
Spinal muscular atrophy (43)
Sponsored (5)
Startups (959)
State (1)
Stomach cancer (1)
Supply chain (15)
Tariffs (14)
The Weekly (33)
United States (7850)
Vaccines (163)
Venture capitalists (16)
Weight loss (58)
Women's health (7)
Worklife (12)
Date
Last 7 days (161)
Last 30 days (876)
Last 365 days (11770)
2025 (3198)
2024 (12552)
2023 (14346)
2022 (16202)
2021 (17844)
2020 (15213)
2019 (10001)
2018 (7150)
2017 (8949)
2016 (7309)
2015 (9302)
2014 (7062)
2013 (5085)
2012 (4915)
2011 (4844)
2010 (4810)
Location
Africa (165)
Alabama (18)
Arizona (19)
Arkansas (2)
Asia (13543)
Australia (1485)
California (2190)
Canada (510)
China (308)
Colorado (80)
Connecticut (89)
Delaware (72)
Europe (24518)
Florida (278)
Georgia (71)
Idaho (3)
Illinois (104)
India (7)
Indiana (81)
Iowa (5)
Japan (59)
Kansas (52)
Kentucky (7)
Maine (2)
Maryland (229)
Massachusetts (1752)
Michigan (35)
Minnesota (75)
Missouri (17)
Nebraska (6)
Nevada (4)
New Hampshire (4)
New Jersey (797)
New Mexico (7)
New York (744)
North Carolina (349)
Northern California (1053)
Ohio (67)
Oklahoma (4)
Oregon (12)
Pennsylvania (402)
Puerto Rico (6)
Rhode Island (7)
South America (210)
Southern California (836)
Tennessee (8)
Texas (215)
Utah (50)
Virginia (42)
Washington D.C. (13)
Washington State (150)
Wisconsin (9)
170,007 Results for "arbutus biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Arbutus Down to ‘Core Team’ After Laying Off More Than Half of Staff
Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The company’s focus is now an RNAi asset for hepatitis B.
March 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
March 4, 2025
·
4 min read
Policy
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Arbutus Biopharma Corporation today issued the following statement regarding the claim construction ruling of the U.S. District Court for the District of Delaware in the lawsuit brought by Arbutus and its licensee Genevant Sciences (Plaintiffs) against Moderna.
April 4, 2024
·
5 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
April 3, 2025
·
1 min read
·
Angela Gabriel
Pharm Country
Arbutus to Participate in Jefferies Global Healthcare Conference
Arbutus Biopharma Corporation today announced that the Arbutus management team will present at and host one-on-one meetings at the following upcoming investor conference being held in New York.
May 29, 2024
·
1 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Press Releases
Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO
February 26, 2025
·
2 min read
Press Releases
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
March 28, 2025
·
16 min read
Editorial
Biopharma Professionals Know All Too Well What Laid-Off HHS Employees Are Experiencing
Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals lost their jobs in the first quarter.
April 11, 2025
·
2 min read
·
Angela Gabriel
Pharm Country
Arbutus to Participate in Two Upcoming May 2024 Investor Conferences
Arbutus Biopharma Corporation announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences which are being held in New York.
May 7, 2024
·
1 min read
1 of 17,001
Next
